FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:1641 June 3, 1993 Number 22 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by The Felbamate Study Group in Lennox-Gastaut Syndrome

To the Editor: The modest decrease in the numbers of parent-reported seizures in children receiving felbamate (Jan. 7 issue)¹ is encouraging, but the results were disappointing in several respects.

The frequency of seizures during the base-line period was greater in the felbamate group than in the placebo group. Some of the improvement in the felbamate group could therefore have been due to regression to the mean. This possibility would be supported by a correlation between the base-line frequency of seizures and the decrease in seizures during treatment. The number of seizures recorded during the videotelemetry sessions was similar in the . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.